FI973040A0 - Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa - Google Patents
Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessaInfo
- Publication number
- FI973040A0 FI973040A0 FI973040A FI973040A FI973040A0 FI 973040 A0 FI973040 A0 FI 973040A0 FI 973040 A FI973040 A FI 973040A FI 973040 A FI973040 A FI 973040A FI 973040 A0 FI973040 A0 FI 973040A0
- Authority
- FI
- Finland
- Prior art keywords
- levobupivacaine
- aesthetics
- preparation
- carboxanilide
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Beans For Foods Or Fodder (AREA)
- Rolling Contact Bearings (AREA)
- Optical Head (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9501071 | 1995-01-18 | ||
GBGB9501071.6A GB9501071D0 (en) | 1995-01-18 | 1995-01-18 | Racemisation |
GB9600067 | 1996-01-12 | ||
PCT/GB1996/000067 WO1996022281A1 (en) | 1995-01-18 | 1996-01-12 | Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
FI973040A0 true FI973040A0 (fi) | 1997-07-17 |
FI973040A FI973040A (fi) | 1997-07-17 |
FI117437B FI117437B (fi) | 2006-10-13 |
Family
ID=10768271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI973040A FI117437B (fi) | 1995-01-18 | 1997-07-17 | Menetelmä optisesti rikastetun levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidiyhdisteiden rasemisoimiseksi |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0804417B1 (fi) |
JP (1) | JP4015696B2 (fi) |
KR (1) | KR100404390B1 (fi) |
CN (1) | CN1172912C (fi) |
AT (1) | ATE242214T1 (fi) |
AU (1) | AU701221B2 (fi) |
BR (1) | BR9606821A (fi) |
CA (1) | CA2208522C (fi) |
DE (1) | DE69628540T2 (fi) |
DK (1) | DK0804417T3 (fi) |
ES (1) | ES2201166T3 (fi) |
FI (1) | FI117437B (fi) |
GB (1) | GB9501071D0 (fi) |
HU (1) | HU227426B1 (fi) |
MX (1) | MX9705428A (fi) |
NO (1) | NO308843B1 (fi) |
PL (1) | PL184091B1 (fi) |
PT (1) | PT804417E (fi) |
WO (1) | WO1996022281A1 (fi) |
ZA (1) | ZA96403B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0002246A (pt) | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
ATE482695T1 (de) | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
LT2767292T (lt) | 2004-09-17 | 2016-12-12 | Durect Corporation | Palaikomosios vietinės anestezijos mišinys su saib |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
DK2117521T3 (da) | 2006-11-03 | 2012-09-03 | Durect Corp | Transdermale indgivelsessystemer omfattende bupivacain |
AU2008335809A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
CN102093284B (zh) * | 2010-12-29 | 2013-05-08 | 宜昌人福药业有限责任公司 | 富集哌啶-2-甲酰苯胺类旋光化合物的方法 |
TW201521769A (zh) | 2013-03-15 | 2015-06-16 | Durect Corp | 具有流變改質劑以減少溶解變異性之組成物 |
CN106187864B (zh) * | 2016-07-11 | 2018-11-23 | 江苏天和制药有限公司 | 一种由盐酸布比卡因制备高纯度布比卡因碱的方法 |
BR112022013784A2 (pt) | 2020-01-13 | 2022-10-11 | Durect Corp | Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados |
WO2023158722A2 (en) * | 2022-02-16 | 2023-08-24 | Teva Pharmaceuticals International Gmbh | Processes for preparation of avacopan and intermediates thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2301498A1 (fr) * | 1975-02-20 | 1976-09-17 | Maggioni & C Spa | Methode pour la racemisation d'une lysine optiquement active |
-
1995
- 1995-01-18 GB GBGB9501071.6A patent/GB9501071D0/en active Pending
-
1996
- 1996-01-12 PT PT96900349T patent/PT804417E/pt unknown
- 1996-01-12 DK DK96900349T patent/DK0804417T3/da active
- 1996-01-12 CA CA002208522A patent/CA2208522C/en not_active Expired - Lifetime
- 1996-01-12 MX MX9705428A patent/MX9705428A/es unknown
- 1996-01-12 AT AT96900349T patent/ATE242214T1/de active
- 1996-01-12 EP EP96900349A patent/EP0804417B1/en not_active Expired - Lifetime
- 1996-01-12 ES ES96900349T patent/ES2201166T3/es not_active Expired - Lifetime
- 1996-01-12 BR BR9606821A patent/BR9606821A/pt unknown
- 1996-01-12 DE DE69628540T patent/DE69628540T2/de not_active Expired - Lifetime
- 1996-01-12 AU AU43948/96A patent/AU701221B2/en not_active Expired
- 1996-01-12 CN CNB961915242A patent/CN1172912C/zh not_active Expired - Lifetime
- 1996-01-12 WO PCT/GB1996/000067 patent/WO1996022281A1/en active IP Right Grant
- 1996-01-12 JP JP52210296A patent/JP4015696B2/ja not_active Expired - Lifetime
- 1996-01-12 KR KR1019970704822A patent/KR100404390B1/ko not_active IP Right Cessation
- 1996-01-12 HU HU9901418A patent/HU227426B1/hu unknown
- 1996-01-12 PL PL96321378A patent/PL184091B1/pl unknown
- 1996-01-18 ZA ZA96403A patent/ZA96403B/xx unknown
-
1997
- 1997-07-17 FI FI973040A patent/FI117437B/fi not_active IP Right Cessation
- 1997-07-17 NO NO973312A patent/NO308843B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69628540D1 (de) | 2003-07-10 |
JPH11501905A (ja) | 1999-02-16 |
NO973312D0 (no) | 1997-07-17 |
MX9705428A (es) | 1997-11-29 |
ATE242214T1 (de) | 2003-06-15 |
KR100404390B1 (ko) | 2004-01-31 |
NO973312L (no) | 1997-07-17 |
HUP9901418A3 (en) | 2001-01-29 |
AU4394896A (en) | 1996-08-07 |
KR19980701432A (ko) | 1998-05-15 |
NO308843B1 (no) | 2000-11-06 |
CN1168134A (zh) | 1997-12-17 |
PT804417E (pt) | 2003-09-30 |
BR9606821A (pt) | 1997-12-23 |
HUP9901418A2 (hu) | 1999-08-30 |
EP0804417A1 (en) | 1997-11-05 |
GB9501071D0 (en) | 1995-03-08 |
DE69628540T2 (de) | 2004-01-08 |
EP0804417B1 (en) | 2003-06-04 |
CN1172912C (zh) | 2004-10-27 |
DK0804417T3 (da) | 2003-10-06 |
CA2208522A1 (en) | 1996-07-25 |
PL321378A1 (en) | 1997-12-08 |
FI117437B (fi) | 2006-10-13 |
HU227426B1 (en) | 2011-05-30 |
WO1996022281A1 (en) | 1996-07-25 |
ZA96403B (en) | 1997-01-20 |
AU701221B2 (en) | 1999-01-21 |
FI973040A (fi) | 1997-07-17 |
CA2208522C (en) | 2007-03-13 |
PL184091B1 (pl) | 2002-08-30 |
JP4015696B2 (ja) | 2007-11-28 |
ES2201166T3 (es) | 2004-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI973040A (fi) | Rasemointimenetelmä käytettäväksi levobupivakaiinin ja siihen läheisesti liittyvien piperidiinikarboksanilidipuudutusaineiden valmistuksessa | |
DE69629670D1 (de) | Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen | |
AU3738597A (en) | Molecular model for vla-4 inhibitors | |
DE69606210D1 (de) | Doppelkammerbehälter und Verfahren zu seiner Herstellung | |
TR199800011T1 (xx) | Benzo$g] kuinolin t�revleri | |
DK0859766T3 (da) | Chirale methylphenyloxazolidinoner | |
ATE217633T1 (de) | Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel | |
DE69632193D1 (de) | Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel | |
DE69624825D1 (de) | Eintopfverfahren zur herstellung von 2-oxazolidinonderivate | |
TR199800608A3 (tr) | Propanolamin türevleri, bunlarin üretim usulü. | |
NO961000D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike | |
DE69300062D1 (de) | Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon. | |
DE59604829D1 (de) | Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin | |
ATE259369T1 (de) | Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen | |
NO304828B1 (no) | Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt | |
DK0914605T3 (da) | Molekylemodel for VLA-4-inhibitorer | |
DE69610837D1 (de) | Verfahren zur herstellung von laubholzelementen | |
DK1246790T3 (da) | Substituerede 1- og 2-naphthol-Mannichbaser | |
ATE237621T1 (de) | Herstellung von einem kristallinen amoxicillinsalz | |
ATE241356T1 (de) | Verlängerung der expression von transgenen proteinen durch immunmodulierende behandlung mit 15-deoxyspergualin | |
ATE212969T1 (de) | Verfahren zur herstellung von 2-halogenindan-1- onen | |
DE69802171D1 (de) | Verfahren zur herstellung von 10,11-dihydro-5h-dibenzo(a,d)cyclohept-5-enen und ihren derivaten | |
ATE236192T1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
NO20023386D0 (no) | Pseudopolymorf av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on | |
DE59808476D1 (de) | VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ENTHALTEND HMG-CoA- REDUKTASEINHIBITOREN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 117437 Country of ref document: FI |
|
MA | Patent expired |